Key points are not available for this paper at this time.
Nondisruptive mutations in the TP53 gene are an independent prognostic factor of shorter survival in advanced NSCLC.
Share your take
Add a clinician perspective alongside expert commentary.
Molina‐Vila et al. (Thu,) studied this question.